Solutions
Strategy & Insight
Position assets and organizations for success through insight generation and strategic decision-making

Insight

Strategy Consulting
Real World Evidence
Illuminate your path to market by leveraging real world data and insights to substantiate your value story and facilitate stakeholder decision-making

Learn more
Value, Access & Outcomes
Uncover the full potential of your products and demonstrate their value and effectiveness to stakeholders around the world

HEOR

Market Access
Medical Strategy & Communications
Effectively articulate your scientific breakthrough to enable healthcare providers, regulators, payers, and patients to understand the value of your product

Learn more
Company
Lumanity is about transformation; we apply incisive thinking and decisive action to cut through complex situations and deliver transformative outcomes to accelerate and optimize access to medical advances Our Story
Meet our team of passionate, collaborative people who inspire incisive thinking and decisive action

Leadership

Our Experts
Every idea, every step in the right direction, matters. Learn about our longstanding beliefs

Social Responsibility

Diversity, Equity, and Inclusion
Focus
Innovation doesn’t guarantee success. But when diverse minds come together to focus on key issues, incredible change can unfold. Lumanity embraces unique viewpoints and experiences to develop better solutions and improved outcomes for patients.
Discover Lumanity's areas of focus

Patient Engagement

Inflation Reduction Act

Cell and Gene Therapy

Biotech

Launch Excellence

Ignite™ Launch Software

KOL Mapping & Engagement Platform
Perspectives
View Expert Perspectives on the Use of Generative AI in Medical Publications

Read More

All Perspectives
Illuminating insights, bold analysis, and transformative visions for decisive action

Case Studies

Views

Resources

Whitepapers

Podcasts

On-Demand Webinars
News
Latest Lumanity CEO Jon Williams named MM+M Pinnacle Award Honoree

Read More

All News
Events
Our experts participate in scientific and clinical events around the world. Connect with us in-person or virtually to discuss how we can transform your business.

Upcoming Events

Upcoming Webinars

On-Demand Webinars
Careers
We are Changemakers. Whether you’re an experienced professional or a recent graduate, join Lumanity to make a difference. We are a collaborative, global team—no matter where you live, you can help us build a healthier world.

Life at Lumanity

Working at Lumanity

Join Our Talent Community
Current Openings
If you want to make a difference, join us. Whether you’re an experienced professional or a recent graduate, together we can build a healthier world.

Openings in North America

Openings in the UK, the European Union, and India

Early Career Positions and Internships

View All
Contact
Get in Touch Interested in learning more about how Lumanity can accelerate and optimize your medical advances? Access to one of our experts is a click away.

Contact Us

Join Us
Locations
Great Suffolk Yard
2nd Floor
131 Great Suffolk Street
London SE1 1PP
United Kingdom

10 North Park Place, Suite 201
Morristown, NJ 07960
United States

More Contact Options
Follow Us

LinkedIn

Twitter

Whitepapers

Patient Insights Across Rare Diseases: Forging better partnerships through collective advocacy

Whitepaper Mar 17, 2022

The Importance of Team Engagement

Whitepaper Feb 22, 2022

Choosing the Right Economic Model to Demonstrate Value for Tumor-Agnostic Therapies

Whitepaper Feb 7, 2022

HTA for Precision Medicines: Evaluating the Impact of Testing Practices, Prognostic Markers, and Other Elements of Value

Whitepaper Jan 7, 2022

Fostering Data Generation to Build the Value Story

Whitepaper Dec 9, 2021

The Value of Insights

Whitepaper Nov 30, 2021

Estimating Comparative Effectiveness Using Single-Arm Trials: Overcoming Additional Challenges in the Tumour-Agnostic Space

Whitepaper Nov 30, 2021

A Subscription to Innovation: Could NHS England’s Novel Frameworks for Antimicrobials Be the Future of HTA?

Whitepaper Sep 24, 2021

Heterogeneity & Generalizability: The Core Difficulties in Estimating the Effectiveness of Tumour-Agnostic Drugs in Practice

Whitepaper Sep 3, 2021

Understanding the Payer Mindset Throughout the Brand Journey

Whitepaper Aug 9, 2021

An Introduction to Planning for HTA for Tumour-Agnostic Cancer Drugs

Therapies designed to target cancers with specific molecular signatures have reshaped the landscape of oncological drug development.¹ The advent of tumour-agnostic therapies represents both a major opportunity for patients to receive therapies targeted to their specific disease on a molecular level and an important step towards discovering biomarkers of response.

Whitepaper Aug 4, 2021

Are There Only 10 Commercial Strategies in Pharma?

Whitepaper May 19, 2021

Connecting the Dots: Harnessing Real World Data in Healthcare Decision Making

Whitepaper May 13, 2021

Next Wave Anti-Cancer Therapies: Part 1

Whitepaper Apr 29, 2021

Five Learnings Manufacturers Should Take from the Latest NICE Guidance on Survival Modelling

Whitepaper Apr 26, 2021

Navigating the Post-COVID Landscape

In this paper we highlight several key themes and recommendations that are essential to consider when navigating our new market environment post COVID-19.

Whitepaper Mar 19, 2021

1 2 3 4 5